1 |
Pinho J, Costa AS, Araújo JM, et al. Intracerebral hemorrhage outcome: a comprehensive update[J]. J Neurol Sci, 2019, 398: 54-66.
|
2 |
MacKey J, Khoury JC, Alwell K, et al. Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population[J]. Neurology, 2016, 87(21): 2192-2197.
|
3 |
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980‒2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736-1788.
|
4 |
Lauridsen SV, Hvas AM, Sandgaard E, et al. Coagulation profile after spontaneous intracerebral hemorrhage: a cohort study[J]. J Stroke Cerebrovasc Dis, 2018, 27(11): 2951-2961.
|
5 |
Fujii Y, Takeuchi S, Harada A, et al. Hemostatic activation in spontaneous intracerebral hemorrhage[J]. Stroke, 2001, 32(4): 883-890.
|
6 |
Abulhasan YB, Alabdulraheem N, Simoneau G, et al. Mortality after spontaneous subarachnoid hemorrhage: causality and validation of a prediction model[J]. World Neurosurg, 2018, 112: e799-e811.
|
7 |
Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke for the 21st century[J]. Stroke, 2013, 44(7): 2064-2089.
|
8 |
Kawano-Castillo J, Ward E, Elliott A, et al. Thrombelastography detects possible coagulation disturbance in patients with intracerebral hemorrhage with hematoma enlargement[J]. Stroke, 2014, 45(3): 683-688.
|
9 |
Chen CW, Wu EH, Huang J, et al. Dynamic evolution of D-dimer level in cerebrospinal fluid predicts poor outcome in patients with spontaneous intracerebral hemorrhage combined with intraventricular hemorrhage[J]. J Clin Neurosci, 2016, 29: 149-154.
|
10 |
Kogan AE, Mukharyamova KS, Bereznikova AV, et al. Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products[J]. Blood Coagul Fibrinolysis, 2016, 27(5): 542-550.
|
11 |
Wu Y, Xiao YX, Huang TY, et al. What makes D-dimer assays suspicious-heterophilic antibodies?[J]. J Clin Lab Anal, 2019, 33(2): e22687.
|
12 |
Boluijt J, Meijers JC, Rinkel GJ, et al. Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review[J]. J Cereb Blood Flow Metab, 2015, 35(5): 724-733.
|
13 |
Lauridsen SV, Hvas CL, Sandgaard E, et al. No hyperfibrinolysis following subarachnoid or intracerebral haemorrhage: a prospective cohort study[J]. Blood Coagul Fibrinolysis, 2019, 30(7): 341-349.
|
14 |
Fukuda H, Lo B, Yamamoto Y, et al. Plasma D-dimer may predict poor functional outcomes through systemic complications after aneurysmal subarachnoid hemorrhage[J]. J Neurosurg, 2017, 127(2): 284-290.
|
15 |
Larsen CC, Hansen-Schwartz J, Nielsen JD, et al. Blood coagulation and fibrinolysis after experimental subarachnoid hemorrhage[J]. Acta Neurochir (Wien), 2010, 152(9): 1577-1581.
|
16 |
Ji Y, Meng QH, Wang ZG. Changes in the coagulation and fibrinolytic system of patients with subarachnoid hemorrhage[J]. Neurol Med Chir (Tokyo), 2014, 54(6): 457-464.
|
17 |
Garton T, Hua Y, Xiang JM, et al. Challenges for intraventricular hemorrhage research and emerging therapeutic targets[J]. Expert Opin Ther Targets, 2017, 21(12): 1111-1122.
|
18 |
Wilkinson DA, Pandey AS, Thompson BG, et al. Injury mechanisms in acute intracerebral hemorrhage[J]. Neuropharmacology, 2018, 134(Pt B): 240-248.
|